An iPSC line derived from a human acute myeloid leukemia cell line (HL-60-iPSC) retains leukemic abnormalities and displays myeloid differentiation defects-Reference-Cited by-同舟云学术

An iPSC line derived from a human acute myeloid leukemia cell line (HL-60-iPSC) retains leukemic abnormalities and displays myeloid differentiation defects

Published:2020-12 Issue: Volume:49 Page:102096
ISSN:1873-5061
Container-title:Stem Cell Research
language:en
Short-container-title:Stem Cell Research

Author:

Yamasaki Amanda E.,Warshaw Jane N.,Kyalwazi Beverly L.,Matsui Hiroko,Jepsen Kristen,Panopoulos Athanasia D.

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference5 articles.

1. Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells;Choi;Nat. Protocols,2011

2. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3;Dalton;Blood,1988

3. High-throughput and cost-effective characterization of induced pluripotent stem cells;D'Antonio;Stem Cell Rep.,2017

4. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia;Gallagher;Blood,1979

5. iPSCORE: a resource of 222 iPSC lines enabling functional characterization of genetic variation across a variety of cell types;Panopoulos;Stem Cell Rep.,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of 3D-iNET ORION: a novel, pre-clinical, three-dimensional in vitro cell model for modeling human metastatic neuroendocrine tumor of the pancreas;Human Cell;2024-08-05

2. The Immune Resistance Signature of Acute Myeloid Leukemia and Current Immunotherapy Strategies;Cancers;2024-07-23

3. Generation of induced pluripotent stem cell line NIMHi010-A from dermal fibroblast cells of a healthy individual;Stem Cell Research;2024-04

4. Recent advances in the application of induced pluripotent stem cell technology to the study of myeloid malignancies;Advances in Biological Regulation;2023-09

5. Reprogramming of Acute Myeloid Leukemia Patients Cells: Harboring Cancer Mutations Requires Targeting of AML Hierarchy;Stem Cells Translational Medicine;2023-05-24